Specialty Pharmacy

Women in Specialty Pharmacy Lunch brings together leaders from various aspects of the specialty landscape.

Beth Wallace discusses various treatments for leiomyosarcoma, including doxorubicin (Adriamycin), nicknamed the red devil.

Payer requirements for outcomes data are becoming more stringent.

Testing and treatment programs should focus on populations driving new cases of hepatitis C virus.

Outcomes and accreditation measures are among the key factors in building a successful specialty pharmacy, according to a session at the annual NASP meeting.

Becoming an accredited specialty pharmacy requires a large time investment and a significant commitment to properly record and report specific data.

Nearly 80% of Americans said they would follow their pharmacist on social media.

Top news of the day from across the health care landscape.

Gadolinium-containing imaging agent could improve breast cancer survival.

The Drug Quality and Security Act provides a foundation for improving the safety of drug compounding by working with outsourcing facilities to meet regulatory standards.

In part 2, Beth Wallace describes the events leading up to her diagnosis with leiomyosarcoma.

Data from a phase 2 trial demonstrates positive results on improving the disabling symptoms of a rare form of autism.

Genentech is seeking approval for Perjeta used in combination with trastuzumab and chemotherapy for adjuvant treatment of HER2-positive early breast cancer.

Consolidative radiation followed by chemotherapy could play a key role in future survival outcomes among patients with non-small cell lung cancer.

Top news of the day from across the health care landscape.

New findings suggest alterations in this process may trigger cancer progression.

Top news of the week from Specialty Pharmacy Times.

Rebecca Shanahan, NASP president and CEO of Avella Specialty Pharmacy, announced the Distinguished Service Award and the Specialty Pharmacy of the Year Award.

Certified specialty pharmacists have greater opportunities and credibility in the growing market, according to a session at the annual NASP meeting.

The Improving Transparency and Accuracy in Medicare Part D Spending Act would end direct and indirect remuneration fees.

Top news of the day from across the health care landscape.

Inhibiting neuroligin-3 in mice delayed the proliferation of high-grade glioma.

The 3-in-1 antibody protected laboratory monkeys from SHIV.

FDA advisory committee votes the data was inconclusive on ataluren (translarna), a first-in-class oral treatment for Duchenne muscular dystrophy.

In part 1 of 2, Beth Wallace shares her journey leading up to her diagnosis with leiomyosarcoma.

Verzenio can be administered as a stand-alone treatment to patients previously treated with endocrine therapy and chemotherapy.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Ron Lanton III, Esq, discusses all things biosimilar during a session at the National Association of Specialty Pharmacy (NASP) Annual Meeting and Educational Conference.